Amphastar Pharmaceuticals (AMPH) Other Operating Expenses (2016 - 2025)
Historic Other Operating Expenses for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $16.9 million.
- Amphastar Pharmaceuticals' Other Operating Expenses rose 4954.8% to $16.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.4 million, marking a year-over-year increase of 2520.91%. This contributed to the annual value of $37.8 million for FY2024, which is 3101.58% up from last year.
- Amphastar Pharmaceuticals' Other Operating Expenses amounted to $16.9 million in Q3 2025, which was up 4954.8% from $10.2 million recorded in Q2 2025.
- In the past 5 years, Amphastar Pharmaceuticals' Other Operating Expenses registered a high of $16.9 million during Q3 2025, and its lowest value of $4.1 million during Q4 2021.
- For the 5-year period, Amphastar Pharmaceuticals' Other Operating Expenses averaged around $7.8 million, with its median value being $6.7 million (2023).
- Per our database at Business Quant, Amphastar Pharmaceuticals' Other Operating Expenses soared by 7611.99% in 2024 and then skyrocketed by 54.03% in 2025.
- Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Other Operating Expenses stood at $4.1 million in 2021, then surged by 34.28% to $5.5 million in 2022, then surged by 57.51% to $8.6 million in 2023, then increased by 20.94% to $10.4 million in 2024, then surged by 61.89% to $16.9 million in 2025.
- Its last three reported values are $16.9 million in Q3 2025, $10.2 million for Q2 2025, and $11.9 million during Q1 2025.